| Year |
Citation |
Score |
| 2024 |
Greguletz P, Plötz M, Baade-Büttner C, Bien CG, Eisenhut K, Geis C, Handreka R, Klausewitz J, Körtvelyessy P, Kovac S, Kraft A, Lewerenz J, Malter M, Nagel M, von Podewils F, et al. Different pain phenotypes are associated with anti-Caspr2 autoantibodies. Journal of Neurology. PMID 38386048 DOI: 10.1007/s00415-024-12224-4 |
0.498 |
|
| 2023 |
Theis H, Bischof GN, Brüggemann N, Dargvainiene J, Drzezga A, Grüter T, Lewerenz J, Leypoldt F, Neumaier B, Wandinger KP, Ayzenberg I, van Eimeren T. In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using [18F]PI-2620 PET. Neurology. 101: e2325-e2330. PMID 37879939 DOI: 10.1212/WNL.0000000000207870 |
0.508 |
|
| 2023 |
Brauchle F, Rapp D, Senel M, Huss A, Dreyhaupt J, Klose V, Süße M, Stürner KH, Leypoldt F, Tumani H, Lewerenz J. Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases - a retrospective cross-sectional study. Frontiers in Neurology. 14: 1193015. PMID 37396770 DOI: 10.3389/fneur.2023.1193015 |
0.505 |
|
| 2022 |
Madlener M, Strippel C, Thaler FS, Doppler K, Wandinger KP, Lewerenz J, Ringelstein M, Roessling R, Menge T, Wickel J, Kellingshaus C, Mues S, Kraft A, Linsa A, Tauber SC, et al. Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response. Journal of the Neurological Sciences. 445: 120540. PMID 36608627 DOI: 10.1016/j.jns.2022.120540 |
0.54 |
|
| 2022 |
Kaaden T, Madlener M, Angstwurm K, Bien CG, Bogarin Y, Doppler K, Finke A, Gerner ST, Reimann G, Häusler M, Handreka R, Hellwig K, Kaufmann M, Kellinghaus C, Koertvelyessy P, ... ... Lewerenz J, et al. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 36266054 DOI: 10.1212/NXI.0000000000200034 |
0.532 |
|
| 2022 |
Gövert F, Abrante L, Becktepe J, Balint B, Ganos C, Hofstadt-van Oy U, Krogias C, Varley J, Irani SR, Paneva S, Titulaer MJ, de Vries JM, Boon AJW, Schreurs MWJ, Joubert B, ... ... Lewerenz J, et al. Distinct movement disorders in contactin-associated-protein-like-2 antibody associated autoimmune encephalitis. Brain : a Journal of Neurology. PMID 35875984 DOI: 10.1093/brain/awac276 |
0.504 |
|
| 2022 |
Strippel C, Herrera-Rivero M, Wendorff M, Tietz AK, Degenhardt F, Witten A, Schroeter C, Nelke C, Golombeck KS, Madlener M, Rüber T, Ernst L, Racz A, Baumgartner T, Widman G, ... ... Lewerenz J, et al. A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies. Brain : a Journal of Neurology. PMID 35348614 DOI: 10.1093/brain/awac119 |
0.532 |
|
| 2022 |
Grüter T, Möllers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, Kraft A, Höftberger R, Schöberl F, Thaler FS, Wickel J, Chung HY, Seifert F, Tschernatsch M, ... ... Lewerenz J, et al. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain : a Journal of Neurology. PMID 35259208 DOI: 10.1093/brain/awac090 |
0.531 |
|
| 2022 |
Endres D, Lüngen E, Hasan A, Kluge M, Fröhlich S, Lewerenz J, Bschor T, Haußleiter IS, Juckel G, Then Bergh F, Ettrich B, Kertzscher L, Oviedo-Salcedo T, Handreka R, Lauer M, et al. Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany. Molecular Psychiatry. PMID 35046526 DOI: 10.1038/s41380-021-01396-4 |
0.533 |
|
| 2021 |
Dürr M, Nissen G, Sühs KW, Schwenkenbecher P, Geis C, Ringelstein M, Hartung HP, Friese MA, Kaufmann M, Malter MP, Madlener M, Thaler FS, Kümpfel T, Senel M, Häusler MG, ... ... Lewerenz J, et al. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34697224 DOI: 10.1212/NXI.0000000000001086 |
0.512 |
|
| 2021 |
Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A, Sühs KW, Wickel J, Geis C, Markewitz R, Urbanek C, Sommer C, Doppler K, Penner L, Lewerenz J, et al. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34599001 DOI: 10.1212/NXI.0000000000001088 |
0.466 |
|
| 2021 |
Tietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, Golombeck KS, Handreka R, Kaufmann M, Kraemer M, Kraft A, Lewerenz J, Lieb W, Madlener M, et al. Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34584012 DOI: 10.1212/NXI.0000000000001085 |
0.524 |
|
| 2019 |
Blinder T, Lewerenz J. Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis. Frontiers in Neurology. 10: 804. PMID 31404257 DOI: 10.3389/Fneur.2019.00804 |
0.323 |
|
| 2019 |
Schubert J, Brämer D, Huttner HB, Gerner ST, Fuhrer H, Melzer N, Dik A, Prüss H, Ly LT, Fuchs K, Leypoldt F, Nissen G, Schirotzek I, Dohmen C, Bösel J, ... Lewerenz J, et al. Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e514. PMID 30568992 DOI: 10.1212/Nxi.0000000000000514 |
0.521 |
|
| 2019 |
Tumani H, Petereit HF, Gerritzen A, Groß CC, Huss A, Isenmann S, Jesse S, Khalil M, Lewerenz J, Leypoldt F, Melzer N, Meuth SG, Otto M, Ruprecht K, Sindern E, et al. S1-Leitlinie: Lumbalpunktion und Liquordiagnostik Dgneurologie. 2: 456-480. DOI: 10.1007/s42451-019-00126-z |
0.438 |
|
| 2018 |
Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O. Admission diagnoses of patients later diagnosed with autoimmune encephalitis. Journal of Neurology. PMID 30421340 DOI: 10.1007/S00415-018-9105-3 |
0.553 |
|
| 2018 |
Lewerenz J, Ates G, Methner A, Conrad M, Maher P. Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System. Frontiers in Neuroscience. 12: 214. PMID 29731704 DOI: 10.3389/Fnins.2018.00214 |
0.629 |
|
| 2018 |
Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, et al. Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Annals of Neurology. PMID 29572931 DOI: 10.1002/Ana.25216 |
0.554 |
|
| 2017 |
Pfeiffer A, Schneider J, Bueno D, Dolga A, Voss TD, Lewerenz J, Wüllner V, Methner A. Bcl-xL knockout attenuates mitochondrial respiration and causes oxidative stress that is compensated by pentose phosphate pathway activity. Free Radical Biology & Medicine. PMID 28807815 DOI: 10.1016/J.Freeradbiomed.2017.08.007 |
0.609 |
|
| 2017 |
Merckx E, Albertini G, Paterka M, Jensen C, Albrecht P, Dietrich M, Van Liefferinge J, Bentea E, Verbruggen L, Demuyser T, Deneyer L, Lewerenz J, van Loo G, De Keyser J, Sato H, et al. Absence of system xc(-) on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis. Journal of Neuroinflammation. 14: 9. PMID 28086920 DOI: 10.1186/S12974-016-0787-0 |
0.637 |
|
| 2017 |
Lewerenz J, Jarius S, Wildemann B, Wandinger KP, Leypoldt F. [Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment]. Der Nervenarzt. 87: 1293-1299. PMID 27847964 DOI: 10.1007/S00115-016-0235-5 |
0.55 |
|
| 2015 |
Lewerenz J, Maher P. Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? Frontiers in Neuroscience. 9: 469. PMID 26733784 DOI: 10.3389/Fnins.2015.00469 |
0.365 |
|
| 2015 |
Fauser S, Uttner I, Ariño H, Scherbaum WA, Saiz A, Lewerenz J. Long latency between GAD-antibody detection and development of limbic encephalitis - a case report. Bmc Neurology. 15: 177. PMID 26420440 DOI: 10.1186/S12883-015-0435-9 |
0.333 |
|
| 2015 |
Massie A, Boillée S, Hewett S, Knackstedt L, Lewerenz J. Main path and byways: non-vesicular glutamate release by system xc (-) as an important modifier of glutamatergic neurotransmission. Journal of Neurochemistry. PMID 26336934 DOI: 10.1111/Jnc.13348 |
0.36 |
|
| 2015 |
Gahr M, Lauda F, Wigand ME, Connemann BJ, Rosenbohm A, Tumani H, Reindl M, Uzelac Z, Lewerenz J. Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania. Bmj Case Reports. 2015. PMID 25917068 DOI: 10.1136/Bcr-2014-209075 |
0.314 |
|
| 2014 |
Pfeiffer A, Jaeckel M, Lewerenz J, Noack R, Pouya A, Schacht T, Hoffmann C, Winter J, Schweiger S, Schäfer MK, Methner A. Mitochondrial function and energy metabolism in neuronal HT22 cells resistant to oxidative stress. British Journal of Pharmacology. 171: 2147-58. PMID 24319993 DOI: 10.1111/Bph.12549 |
0.646 |
|
| 2014 |
Lewerenz J, Baxter P, Kassubek R, Albrecht P, Van Liefferinge J, Westhoff MA, Halatsch ME, Karpel-Massler G, Meakin PJ, Hayes JD, Aronica E, Smolders I, Ludolph AC, Methner A, Conrad M, et al. Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy. Antioxidants & Redox Signaling. 20: 2907-22. PMID 24219064 DOI: 10.1089/Ars.2013.5455 |
0.61 |
|
| 2013 |
Wiesner D, Merdian I, Lewerenz J, Ludolph AC, Dupuis L, Witting A. Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1α and Nrf2. Plos One. 8: e76670. PMID 24098549 DOI: 10.1371/Journal.Pone.0076670 |
0.332 |
|
| 2013 |
Albrecht P, Henke N, Tien ML, Issberner A, Bouchachia I, Maher P, Lewerenz J, Methner A. Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity. Neurochemistry International. 62: 610-9. PMID 23357478 DOI: 10.1016/J.Neuint.2013.01.019 |
0.658 |
|
| 2013 |
Henke N, Albrecht P, Bouchachia I, Ryazantseva M, Knoll K, Lewerenz J, Kaznacheyeva E, Maher P, Methner A. The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death & Disease. 4: e470. PMID 23348584 DOI: 10.1038/Cddis.2012.216 |
0.627 |
|
| 2013 |
Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxidants & Redox Signaling. 18: 522-55. PMID 22667998 DOI: 10.1089/Ars.2011.4391 |
0.628 |
|
| 2012 |
Albrecht P, Bouchachia I, Goebels N, Henke N, Hofstetter HH, Issberner A, Kovacs Z, Lewerenz J, Lisak D, Maher P, Mausberg AK, Quasthoff K, Zimmermann C, Hartung HP, Methner A. Effects of dimethyl fumarate on neuroprotection and immunomodulation. Journal of Neuroinflammation. 9: 163. PMID 22769044 DOI: 10.1186/1742-2094-9-163 |
0.642 |
|
| 2012 |
Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T, Dalmau J, Gerloff C, Lewerenz J. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 681-6. PMID 22566598 DOI: 10.1136/Jnnp-2011-301969 |
0.553 |
|
| 2012 |
Gelderblom M, Leypoldt F, Lewerenz J, Birkenmayer G, Orozco D, Ludewig P, Thundyil J, Arumugam TV, Gerloff C, Tolosa E, Maher P, Magnus T. The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 835-43. PMID 22234339 DOI: 10.1038/Jcbfm.2011.189 |
0.545 |
|
| 2012 |
Lewerenz J, Sato H, Albrecht P, Henke N, Noack R, Methner A, Maher P. Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression. Cell Death and Differentiation. 19: 847-58. PMID 22095285 DOI: 10.1038/Cdd.2011.165 |
0.643 |
|
| 2012 |
Noack R, Frede S, Albrecht P, Henke N, Pfeiffer A, Knoll K, Dehmel T, Meyer Zu Hörste G, Stettner M, Kieseier BC, Summer H, Golz S, Kochanski A, Wiedau-Pazos M, Arnold S, ... Lewerenz J, et al. Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. Human Molecular Genetics. 21: 150-62. PMID 21965300 DOI: 10.1093/Hmg/Ddr450 |
0.613 |
|
| 2012 |
Lewerenz J, Maher P, Methner A. Regulation of xCT expression and system x (c) (-) function in neuronal cells. Amino Acids. 42: 171-9. PMID 21369940 DOI: 10.1007/S00726-011-0862-X |
0.645 |
|
| 2012 |
Lewerenz J, Maher P. The Phosphoinositide 3-Kinase-Mediated Regulation of System Xc- Activity Is Dependent Upon EIF2alpha Phosphorylation and ATF4 and Regulates the Sensitivity of Neuronal Cells to Oxidative Stress Free Radical Biology and Medicine. 53. DOI: 10.1016/J.Freeradbiomed.2012.10.206 |
0.323 |
|
| 2011 |
Choe CU, Lewerenz J, Gerloff C, Magnus T, Donzelli S. Nitroxyl in the central nervous system. Antioxidants & Redox Signaling. 14: 1699-711. PMID 21235347 DOI: 10.1089/Ars.2010.3852 |
0.312 |
|
| 2011 |
Lewerenz J, Maher P. Control of redox state and redox signaling by neural antioxidant systems. Antioxidants & Redox Signaling. 14: 1449-65. PMID 20812872 DOI: 10.1089/Ars.2010.3600 |
0.318 |
|
| 2010 |
Lewerenz J, Dargusch R, Maher P. Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity. Journal of Neurochemistry. 113: 502-14. PMID 20132475 DOI: 10.1111/j.1471-4159.2010.06621.x |
0.419 |
|
| 2010 |
Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. Cns & Neurological Disorders Drug Targets. 9: 373-82. PMID 20053169 DOI: 10.2174/187152710791292567 |
0.646 |
|
| 2010 |
Toutzaris D, Lewerenz J, Albrecht P, Jensen LT, Letz J, Geerts A, Golz S, Methner A. A novel giant peroxisomal superoxide dismutase motif-containing protein. Free Radical Biology & Medicine. 48: 811-20. PMID 20045724 DOI: 10.1016/J.Freeradbiomed.2009.12.023 |
0.666 |
|
| 2009 |
Lewerenz J, Albrecht P, Tien ML, Henke N, Karumbayaram S, Kornblum HI, Wiedau-Pazos M, Schubert D, Maher P, Methner A. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. Journal of Neurochemistry. 111: 332-43. PMID 19694903 DOI: 10.1111/J.1471-4159.2009.06347.X |
0.657 |
|
| 2009 |
Choe CU, Lewerenz J, Fischer G, Uliasz TF, Espey MG, Hummel FC, King SB, Schwedhelm E, Böger RH, Gerloff C, Hewett SJ, Magnus T, Donzelli S. Nitroxyl exacerbates ischemic cerebral injury and oxidative neurotoxicity. Journal of Neurochemistry. 110: 1766-73. PMID 19619135 DOI: 10.1111/J.1471-4159.2009.06266.X |
0.357 |
|
| 2006 |
Sahin M, Saxena A, Joost P, Lewerenz J, Methner A. Induction of Bcl-2 by functional regulation of G-protein coupled receptors protects from oxidative glutamate toxicity by increasing glutathione. Free Radical Research. 40: 1113-23. PMID 17050165 DOI: 10.1080/10715760600838191 |
0.655 |
|
| 2006 |
Leypoldt F, Eichhorn P, Saager C, Münchau A, Lewerenz J. Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 1199-200. PMID 16980662 DOI: 10.1136/Jnnp.2005.086140 |
0.555 |
|
| 2006 |
Lewerenz J, Klein M, Methner A. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity. Journal of Neurochemistry. 98: 916-25. PMID 16771835 DOI: 10.1111/J.1471-4159.2006.03921.X |
0.656 |
|
| 2006 |
Lewerenz J, Methner A. Mechanismen und Bedeutung der oxidativen Glutamattoxizität E-Neuroforum. 12. DOI: 10.1515/Nf-2006-0303 |
0.527 |
|
| 2006 |
Lewerenz J, Methner A. Mechanisms and role of oxidative glutamate toxicity | Mechanismen und Bedeutung der oxidativen Glutamattoxizität Neuroforum. 12: 222-227. |
0.585 |
|
| 2005 |
Lewerenz J, Hagel C, Matschke J, Lennon V, Leypoldt F. Paraneoplastic multifocal neuropathy with anti-CRMP5- and anti-amphiphysin antibodies and myositis preceeding recurrence of a small-cell bladder carcinoma Aktuelle Neurologie. 32. DOI: 10.1055/S-2005-919627 |
0.494 |
|
| 2005 |
Leypoldt F, Münchau A, Lewerenz J. Ein Fall einer paraneoplastischen Myelitis mit Anti-Ri-Antikörpern: Steuerung einer dreijährigen immunsuppressiven Therapie anhand klinischer und paraklinischer Parameter Aktuelle Neurologie. 32. DOI: 10.1055/S-2005-919408 |
0.462 |
|
| 2004 |
Klein M, Methner A, Lewerenz J. Excitatory amino acid transporter 3 and the glutamate/cystine antiporter system Xc- cooperatively protect neuronal HT22 cells from oxidative glutamate toxicity Aktuelle Neurologie. 31. DOI: 10.1055/S-2004-833373 |
0.611 |
|
| 2003 |
Lewerenz J, Thomsen S, Steinbeck JA, Methner A. Short-term serum supplementation improves glucose-oxygen deprivation in primary cortical cultures grown under serum-free conditions. Methods in Cell Science : An Official Journal of the Society For in Vitro Biology. 25: 227-36. PMID 15801169 |
0.567 |
|
| 2003 |
Lewerenz J, Gocht A, Hoeger PH, von den Driesch P, Eckert B, Lamszus K, Stuerenburg HJ, Methner A. Multiple vascular abnormalities and a paradoxical combination of vitamin B12 deficiency and thrombocytosis in a case with POEMS syndrome. Journal of Neurology. 250: 1488-91. PMID 14673584 DOI: 10.1007/s00415-003-0261-7 |
0.519 |
|
| 2003 |
Lewerenz J, Letz J, Methner A. Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress. Journal of Neurochemistry. 87: 522-31. PMID 14511129 DOI: 10.1046/J.1471-4159.2003.02019.X |
0.668 |
|
| 2003 |
Lewerenz J, Leypoldt F, Methner A. Degenerate suppression PCR identifies the beta2-adrenergic receptor as upregulated by neuronal differentiation. Gene Expression. 11: 105-16. PMID 12837041 DOI: 10.3727/000000003108749008 |
0.689 |
|
| 2001 |
Methner A, Leypoldt F, Joost P, Lewerenz J. Human septin 3 on chromosome 22q13.2 is upregulated by neuronal differentiation. Biochemical and Biophysical Research Communications. 283: 48-56. PMID 11322766 DOI: 10.1006/Bbrc.2001.4741 |
0.681 |
|
| 2001 |
Leypoldt F, Lewerenz J, Methner A. Identification of genes up-regulated by retinoic-acid-induced differentiation of the human neuronal precursor cell line NTERA-2 cl.D1. Journal of Neurochemistry. 76: 806-14. PMID 11158252 DOI: 10.1046/J.1471-4159.2001.00079.X |
0.705 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Jesse S, Wagner J, Gastl R, Steinacker P, Otto M, Kassubek J, Lewerenz J. On Razor's edge: Managing analgosedation during severe anti-NMDA receptor encephalitis. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e522. PMID 30569000 DOI: 10.1212/Nxi.0000000000000522 |
0.296 |
|
| 2007 |
Lewerenz J, Ding X, Matschke J, Schnabel C, Emami P, von Borczyskowski D, Buchert R, Krieger T, de Wit M, Münchau A. Dementia and leukoencephalopathy due to lymphomatosis cerebri. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 777-8. PMID 17210623 DOI: 10.1136/Jnnp.2006.106385 |
0.287 |
|
| 2017 |
Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Martí MJ, Montojo T, Pérez-Pérez J, Puertas I, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. PMID 28381508 DOI: 10.1212/Wnl.0000000000003887 |
0.286 |
|
| 2008 |
Maher P, Lewerenz J, Lozano C, Torres JL. A novel approach to enhancing cellular glutathione levels. Journal of Neurochemistry. 107: 690-700. PMID 18702664 DOI: 10.1111/j.1471-4159.2008.05620.x |
0.278 |
|
| 2016 |
Bentea E, Van Liefferinge J, Verbruggen L, Martens K, Kobayashi S, Deneyer L, Demuyser T, Albertini G, Maes K, Sato H, Smolders I, Lewerenz J, Massie A. Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system xc. Experimental Neurology. PMID 28024798 DOI: 10.1016/J.Expneurol.2016.12.009 |
0.274 |
|
| 2013 |
Süssmuth SD, Brettschneider J, Spreer A, Wick M, Jesse S, Lewerenz J, Otto M, Tumani H. [Current cerebrospinal fluid diagnostics for pathogen-related diseases]. Der Nervenarzt. 84: 229-44. PMID 23371378 DOI: 10.1007/S00115-012-3701-8 |
0.271 |
|
| 2009 |
Lewerenz J, Maher P. Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. The Journal of Biological Chemistry. 284: 1106-15. PMID 19017641 DOI: 10.1074/jbc.M807325200 |
0.265 |
|
| 2019 |
Senel M, Mojib-Yezdani F, Braisch U, Bachhuber F, Lewerenz J, Ludolph AC, Otto M, Tumani H. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort. Frontiers in Immunology. 10: 641. PMID 30984199 DOI: 10.3389/Fimmu.2019.00641 |
0.261 |
|
| 2019 |
Huss A, Mojib-Yezdani F, Bachhuber F, Fangerau T, Lewerenz J, Otto M, Tumani H, Senel M. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 31437445 DOI: 10.1016/J.Cca.2019.08.016 |
0.26 |
|
| 2005 |
Lewerenz J, Zurowski B, Jenicke L, Bäumer T, Lees AJ, Münchau A. Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1071-5. PMID 15838851 DOI: 10.1002/Mds.20484 |
0.258 |
|
| 2018 |
Jeck J, Kassubek R, Coburger J, Edenhofer S, Schönsteiner SS, Ludolph AC, Schmitz B, Engelke J, Mayer-Steinacker R, Lewerenz J, Bullinger L. Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature. Therapeutic Advances in Neurological Disorders. 11: 1756285617753597. PMID 29403545 DOI: 10.1177/1756285617753597 |
0.255 |
|
| 2014 |
Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, SantamarÃa J, Dalmau J, Graus F. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. The Lancet. Neurology. 13: 575-86. PMID 24703753 DOI: 10.1016/S1474-4422(14)70051-1 |
0.254 |
|
| 2015 |
Urbach H, Rauer S, Mader I, Paus S, Wagner J, Malter MP, Prüss H, Lewerenz J, Kassubek J, Hegen H, Auer M, Deisenhammer F, Ufer F, Bien CG, Baumgartner A. Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis. Neuroradiology. PMID 26293130 DOI: 10.1007/S00234-015-1581-X |
0.251 |
|
| 2018 |
Lewerenz J, Steinacker P, Suárez-Calvet M, Dreyhaupt J, Morenas-Rodríguez E, Lehmensiek V, Trautmann S, Haass C, Otto M, Landwehrmeyer GB. D04 Blood-CSF barrier function and CSF flow influence CSF biomarkers in huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.86 |
0.242 |
|
| 2017 |
Kassubek R, Bullinger L, Kassubek J, Dreyhaupt J, Ludolph AC, Althaus K, Lewerenz J. Identifying ischemic stroke associated with cancer: a multiple model derived from a case-control analysis. Journal of Neurology. PMID 28247043 DOI: 10.1007/S00415-017-8432-0 |
0.24 |
|
| 2023 |
Biljecki M, Eisenhut K, Beltrán E, Winklmeier S, Mader S, Thaller A, Eichhorn P, Steininger P, Flierl-Hecht A, Lewerenz J, Kümpfel T, Kerschensteiner M, Meinl E, Thaler FS. Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 36823135 DOI: 10.1212/NXI.0000000000200090 |
0.239 |
|
| 2014 |
Sabater L, Gaig C, Gelpí E, Bataller L, Lewerenz J, Torres-vega E, Contreras A, Giometto B, Compta Y, Iranzo A, Santamaria J, Dalmau J, Graus F. A novel non-rapid-eye movement (REM) and REM parasomnia with sleep breathing disorder associated with antibodies to IgLON5 and tau deposits at post-mortem study Journal of Neuroimmunology. 275: 44-45. DOI: 10.1016/J.Jneuroim.2014.08.118 |
0.228 |
|
| 2017 |
Tsoures E, Lewerenz J, Pinkhardt E, Ludolph AC, Fauser S. Electroencephalographic findings in patients with circumscribed thalamic lesions. Epilepsy Research. 135: 115-122. PMID 28666153 DOI: 10.1016/J.Eplepsyres.2017.06.009 |
0.227 |
|
| 2020 |
Kuehn JC, Scheuerle A, Bauer J, Becker AJ, Wirtz R, Lewerenz J. A 64-Year-Old Patient With a Mesiotemporal Mass and Symptomatic Epilepsy. Brain Pathology (Zurich, Switzerland). 30: 413-414. PMID 32100436 DOI: 10.1111/Bpa.12818 |
0.217 |
|
| 2016 |
Hesse R, Wahler A, Gummert P, Kirschmer S, Otto M, Tumani H, Lewerenz J, Schnack C, von Arnim CA. Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β. Bmc Neurology. 16: 185. PMID 27671345 DOI: 10.1186/S12883-016-0707-Z |
0.216 |
|
| 2015 |
Hawlik A, Wassner A, Ludolph AC, Lewerenz J, Rosenbohm A. Internalized capillaries in skeletal muscle biopsy. Neuromuscular Disorders : Nmd. 25: 94-5. PMID 25307855 DOI: 10.1016/J.Nmd.2014.08.005 |
0.209 |
|
| 2020 |
Voss TD, Gerget M, Linkus B, von Einem B, Landwehrmeyer GB, Lewerenz J. Ubiquitination and the Proteasome rather than Caspase-3-Mediated C-Terminal Cleavage are Involved in the EAAT2 Degradation by Staurosporine-Induced Cellular Stress. Journal of Neurochemistry. PMID 33180957 DOI: 10.1111/jnc.15237 |
0.204 |
|
| 2023 |
Eisenhut K, Faber J, Engels D, Gerhards R, Lewerenz J, Doppler K, Sommer C, Markewitz R, Falk KK, Rössling R, Pruess H, Finke C, Wickel J, Geis C, Ratuszny D, et al. Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies. Neurology(R) Neuroimmunology & Neuroinflammation. 11. PMID 37914416 DOI: 10.1212/NXI.0000000000200176 |
0.2 |
|
| 2021 |
Schwenkenbecher P, Skripuletz T, Lange P, Dürr M, Konen FF, Möhn N, Ringelstein M, Menge T, Friese MA, Melzer N, Malter MP, Häusler M, Thaler FS, Stangel M, Lewerenz J, et al. Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34429365 DOI: 10.1212/NXI.0000000000001062 |
0.169 |
|
| 2023 |
Klose V, Jesse S, Lewerenz J, Kassubek J, Dorst J, Tumani H, Ludolph AC, Roselli F. CSF oligoclonal IgG bands are not associated with ALS progression and prognosis. Frontiers in Neurology. 14: 1170360. PMID 37213901 DOI: 10.3389/fneur.2023.1170360 |
0.158 |
|
| 2020 |
Al Shweiki MR, Oeckl P, Pachollek A, Steinacker P, Barschke P, Halbgebauer S, Anderl-Straub S, Lewerenz J, Ludolph AC, Bernhard Landwehrmeyer G, Otto M. Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides Are Decreased in Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33006791 DOI: 10.1002/mds.28300 |
0.157 |
|
| 2011 |
Bartlett BJ, Isakson P, Lewerenz J, Sanchez H, Kotzebue RW, Cumming RC, Harris GL, Nezis IP, Schubert DR, Simonsen A, Finley KD. p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy. 7: 572-83. PMID 21325881 DOI: 10.4161/Auto.7.6.14943 |
0.144 |
|
| 2021 |
Frank W, Lindenberg KS, Mühlbäck A, Lewerenz J, Landwehrmeyer GB. [Disease-modifying treatment approaches in Huntington disease : Past and future]. Der Nervenarzt. PMID 34762178 DOI: 10.1007/s00115-021-01224-8 |
0.141 |
|
| 2023 |
Gallus M, Roll W, Dik A, Barca C, Zinnhardt B, Hicking G, Mueller C, Naik VN, Anstötz M, Krämer J, Rolfes L, Wachsmuth L, Pitsch J, van Loo KMJ, Räuber S, ... ... Lewerenz J, et al. Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell-mediated limbic encephalitis. Science Advances. 9: eabq7595. PMID 37294768 DOI: 10.1126/sciadv.abq7595 |
0.139 |
|
| 2020 |
Senel M, Rapp D, Mayer B, Jesse S, Süssmuth SD, Otto M, Lewerenz J, Tumani H. Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections. Cells. 9. PMID 32992967 DOI: 10.3390/cells9102169 |
0.133 |
|
| 2009 |
Lewerenz J, Ding XQ, Matschke J, Schnabel C, Emami P, von Borczyskowski D, Buchert R, Krieger T, de Wit M, Münchau A. Dementia and leukoencephalopathy due to lymphomatosis cerebri. Bmj Case Reports. 2009. PMID 21686648 DOI: 10.1136/bcr.08.2008.0752 |
0.125 |
|
| 2022 |
Barschke P, Abu-Rumeileh S, Al Shweiki MHDR, Barba L, Paolini Paoletti F, Oeckl P, Steinacker P, Halbgebauer S, Gaetani L, Lewerenz J, Ludolph AC, Landwehrmeyer GB, Parnetti L, Otto M. Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease. Journal of Neurology. PMID 35737109 DOI: 10.1007/s00415-022-11187-8 |
0.117 |
|
| 2021 |
Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y, Högl B, Lewerenz J, Erro ME, Garcia-Monco JC, Nigro P, Tambasco N, Patalong-Ogiewa M, Erdler M, Macher S, et al. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology. PMID 34380749 DOI: 10.1212/WNL.0000000000012639 |
0.109 |
|
| 2019 |
Brenner D, Baumgartner T, von Spiczak S, Lewerenz J, Weis R, Grimmer A, Gaspirova P, Wurster CD, Kunz WS, Wagner J, Minassian BA, Elger CE, Ludolph AC, Biskup S, Döcker D. Genotypes and phenotypes of patients with Lafora disease living in Germany. Neurological Research and Practice. 1. PMID 32587944 DOI: 10.1186/s42466-019-0040-2 |
0.105 |
|
| 2023 |
van de Zande NA, Bulk M, Najac C, van der Weerd L, de Bresser J, Lewerenz J, Ronen I, de Bot ST. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease. Neuroimage. Clinical. 39: 103450. PMID 37327706 DOI: 10.1016/j.nicl.2023.103450 |
0.099 |
|
| 2020 |
Bulk M, Hegeman-Kleinn I, Kenkhuis B, Suidgeest E, van Roon-Mom W, Lewerenz J, van Duinen S, Ronen I, van der Weerd L. Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington's disease patients. Neuroimage. Clinical. 28: 102498. PMID 33395988 DOI: 10.1016/j.nicl.2020.102498 |
0.094 |
|
| 2022 |
Kehrer-Sawatzki H, Bäzner U, Krämer J, Lewerenz J, Pfeiffer C. The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg. 20: 273-277. PMID 35246941 DOI: 10.1111/ddg.14707 |
0.094 |
|
| 2022 |
Jarius S, Pache F, Körtvelyessy P, Jelčić I, Stettner M, Franciotta D, Keller E, Neumann B, Ringelstein M, Senel M, Regeniter A, Kalantzis R, Willms JF, Berthele A, Busch M, ... ... Lewerenz J, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. Journal of Neuroinflammation. 19: 19. PMID 35057809 DOI: 10.1186/s12974-021-02339-0 |
0.087 |
|
| 2022 |
Rodrigues FB, Owen G, Sathe S, Pak E, Kaur D, Ehrhardt AG, Lifer S, Townhill J, Schubert K, Leavitt BR, Guttman M, Bang J, Lewerenz J, Levey J, Sampaio C, et al. Safety and Feasibility of Research Lumbar Puncture in Huntington's Disease: The HDClarity Cohort and Bioresource. Journal of Huntington's Disease. 11: 59-69. PMID 35253773 DOI: 10.3233/JHD-210508 |
0.074 |
|
| 2021 |
Lang C, Gries C, Lindenberg K, Lewerenz J, Uhl S, Olsson C, Samzelius J, Landwehrmeyer BG. Monitoring the Motor Phenotype in Huntington's Disease by Analysis of Keyboard Typing During Real Life Computer Use. Journal of Huntington's Disease. PMID 33459656 DOI: 10.3233/JHD-200451 |
0.068 |
|
| 2015 |
Lewerenz J, Leypoldt F. Paraneoplastic neurological syndromes Cerebrospinal Fluid in Clinical Neurology. 353-385. DOI: 10.1007/978-3-319-01225-4_21 |
0.066 |
|
| 1989 |
Krasemann EO, Lewerenz J. [School sports--early prevention of coronary heart disease?]. Fortschritte Der Medizin. 107: 375-7. PMID 2663679 |
0.048 |
|
| 2015 |
Urbach H, Rauer S, Mader I, Paus S, Wagner J, Malter MP, Prüss H, Lewerenz J, Kassubek J, Hegen H, Auer M, Deisenhammer F, Ufer F, Bien CG, Baumgartner A. Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis Neuroradiology. DOI: 10.1007/s00234-015-1581-x |
0.038 |
|
| 2022 |
Kehrer-Sawatzki H, Bäzner U, Krämer J, Lewerenz J, Pfeiffer C. Das NF1-Mikrodeletions-Syndrom: Die frühzeitige genetische Diagnose erleichtert den Umgang mit einer klinisch definierten Erkrankung. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg. 20: 273-278. PMID 35304941 DOI: 10.1111/ddg.14707_g |
0.037 |
|
| 2004 |
Lewerenz J, Finckh U, Ding X, Friedl W, Kohlschütter A, Münchau A. Charcot-Marie-Tooth-Erkrankung mit disseminierter Encephalomyelopathie - Kreuzreaktion einer Immunreaktion gegen defektes Myelin? Aktuelle Neurologie. 31. DOI: 10.1055/s-2004-833429 |
0.036 |
|
| 2015 |
Brandt JU, Lewerenz J, Müller-Link D, Reichwage M. Development of a multiphase down-hole twin-screw pump and its use in multiphase-operated transport networks Oil Gas European Magazine. 41: 153-156. |
0.033 |
|
| 1986 |
Krasemann EO, Lewerenz J. [Coronary heart disease--prevention in school]. Fortschritte Der Medizin. 104: 331-5. PMID 3710400 |
0.024 |
|
| 2013 |
Zoladek S, Solarska R, Skorupska K, Rutkowska IA, Wadas A, Bienkowski K, Lewerenz JH, Palys B, Kulesza PJ. Enhancement of photoelectrochemical water splitting and solar energy induced electroreduction of carbon dioxide through utilization of plasmonic and electrocatalytic metal nanoparticles Ecs Transactions. 58: 9-20. DOI: 10.1149/05830.0009ecst |
0.024 |
|
| 1999 |
Lewerenz J, Schewe KD, Thalheim B. Modelling data warehouses and OLAP applications by means of dialogue objects Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 1728: 354-368. |
0.016 |
|
| 2019 |
Tumani H, Lewerenz J, Jesse S. Lumbalpunktion – Schritt für Schritt Neurologie Up2date. 2: 22-28. DOI: 10.1055/a-0754-0920 |
0.01 |
|
| 2011 |
Hatesuer F, Reichwage M, Lewerenz J, Luke A. Pressure pulsations in twin-screw multiphase pumps conveying oil and air Proceedings of the International Offshore and Polar Engineering Conference. 26-32. |
0.01 |
|
| 2008 |
Scharf A, Aleksieva G, Lewerenz J, Reichwage M, Mewes D. Pressure build-up and gap flows in multiphase screw pumps Bhr Group - 6th North American Conference On Multiphase Technology. 103-116. |
0.01 |
|
| 1995 |
Albota M, Koops A, Lewerenz J, Thiele B, Raschke P, Puschel K. HIV prevalence among imprisoned i.v. drug addicts in Hamburg - Comparison of 1992 and 1993 surveys | HIV-PRAVALENZ INTRAVENOS DROGENABHANGIGER IM HAMBURGER STRAFVOLLZUG IM JAHRESVERGLEICH 1992-1993 Aids-Forschung. 10: 127-132. |
0.01 |
|
| Hide low-probability matches. |